An outbreak of the Marburg virus in Rwanda has resulted in the deaths of at least 12 people, with 46 confirmed cases and 29 individuals in isolation. Health officials in Rwanda have initiated a vaccine study to combat the spread of this deadly virus. The Rwanda Biomedical Centre is currently reviewing a shipment of vaccines and has received 700 doses of an under-trial vaccine from the Sabin Vaccine Institute in the US.
Symptoms of the Marburg virus include fever, muscle pains, diarrhea, vomiting, and potential death due to severe blood loss. Most of the infected individuals in Rwanda are health workers in six out of the country’s 30 districts. Strict measures have been put in place to prevent further spread of the virus, including the suspension of school and hospital visits, restrictions on funeral attendance, and a ban on home vigils for victims of Marburg.
Rumors of an outbreak in Germany were sparked by a couple who fell ill after traveling from Frankfurt to Hamburg. However, after testing, it was confirmed that they did not have the Marburg virus. The UK has not imposed a travel ban to Rwanda yet, but the Foreign Office advises caution due to the presence of the virus in health facilities in the country.
Marburg outbreaks and cases have been reported in various countries in the past, including Tanzania, Equatorial Guinea, Angola, Congo, Kenya, South Africa, Uganda, and Ghana. It is important to stay informed and take necessary precautions to prevent the spread of this deadly virus. Stay updated with the latest news and guidelines to protect yourself and your loved ones from the Marburg virus.
